Literature DB >> 19778602

Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovittata.

Yufang Ma1, Cunbao Liu, Xiuhong Liu, Jing Wu, Hailong Yang, Yipeng Wang, Jianxu Li, Haining Yu, Ren Lai.   

Abstract

Much attention has been paid on amphibian peptides for their wide-ranging pharmacological properties, clinical potential, and gene-encoded origin. More than 300 antimicrobial peptides (AMPs) from amphibians have been studied. Peptidomics and genomics analysis combined with functional test including microorganism killing, histamine-releasing, and mast cell degranulation was used to investigate antimicrobial peptide diversity. Thirty-four novel AMPs from skin secretions of Rana nigrovittata were identified in current work, and they belong to 9 families, including 6 novel families. Other three families are classified into rugosin, gaegurin, and temporin family of amphibian AMP, respectively. These AMPs share highly conserved preproregions including signal peptides and spacer acidic peptides, while greatly diversified on mature peptides structures. In this work, peptidomics combined with genomics analysis was confirmed to be an effective way to identify amphibian AMPs, especially novel families. Some AMPs reported here will provide leading molecules for designing novel antimicrobial agents.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19778602     DOI: 10.1016/j.ygeno.2009.09.004

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  16 in total

Review 1.  A mini review on the antimicrobial peptides isolated from the genus Hylarana (Amphibia: Anura) with a proposed nomenclature for amphibian skin peptides.

Authors:  Priya Thomas; T V Vineeth Kumar; V Reshmy; K S Kumar; S George
Journal:  Mol Biol Rep       Date:  2012-02-04       Impact factor: 2.316

2.  Five novel antimicrobial peptides from the Kuhl's wart frog skin secretions, Limnonectes kuhlii.

Authors:  Guoxiang Wang; Ying Wang; Dongying Ma; Huan Liu; Jianxu Li; Keyun Zhang; Xiaolong Yang; Ren Lai; Jingze Liu
Journal:  Mol Biol Rep       Date:  2012-10-10       Impact factor: 2.316

3.  Prediction of Leymus arenarius (L.) antimicrobial peptides based on de novo transcriptome assembly.

Authors:  Anna A Slavokhotova; Andrey A Shelenkov; Tatyana I Odintsova
Journal:  Plant Mol Biol       Date:  2015-09-14       Impact factor: 4.076

4.  Natural antimicrobial peptides as promising anti-HIV candidates.

Authors:  Guangshun Wang
Journal:  Curr Top Pept Protein Res       Date:  2012

Review 5.  Cracking the Challenge of Antimicrobial Drug Resistance with CRISPR/Cas9, Nanotechnology and Other Strategies in ESKAPE Pathogens.

Authors:  Tanzeel Zohra; Muhammad Numan; Aamer Ikram; Muhammad Salman; Tariq Khan; Misbahud Din; Muhammad Salman; Ayesha Farooq; Afreenish Amir; Muhammad Ali
Journal:  Microorganisms       Date:  2021-04-29

6.  A Novel Trypsin Inhibitor-Like Cysteine-Rich Peptide from the Frog Lepidobatrachus laevis Containing Proteinase-Inhibiting Activity.

Authors:  Yu-Wei Wang; Ji-Min Tan; Can-Wei Du; Ning Luan; Xiu-Wen Yan; Ren Lai; Qiu-Min Lu
Journal:  Nat Prod Bioprospect       Date:  2015-09-02

Review 7.  Strategies and molecular tools to fight antimicrobial resistance: resistome, transcriptome, and antimicrobial peptides.

Authors:  Letícia S Tavares; Carolina S F Silva; Vinicius C de Souza; Vânia L da Silva; Cláudio G Diniz; Marcelo O Santos
Journal:  Front Microbiol       Date:  2013-12-31       Impact factor: 5.640

8.  Antimicrobial peptides.

Authors:  Ali Adem Bahar; Dacheng Ren
Journal:  Pharmaceuticals (Basel)       Date:  2013-11-28

9.  Database-Guided Discovery of Potent Peptides to Combat HIV-1 or Superbugs.

Authors:  Guangshun Wang
Journal:  Pharmaceuticals (Basel)       Date:  2013-05-27

Review 10.  Host Defense Peptides from Asian Frogs as Potential Clinical Therapies.

Authors:  Vineeth T V Kumar; David Holthausen; Joshy Jacob; Sanil George
Journal:  Antibiotics (Basel)       Date:  2015-03-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.